Log in to save to my catalogue

Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracte...

Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracte...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8283d0b951404c6ea5a0f214fee70194

Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection

About this item

Full title

Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection

Publisher

Basel: MDPI AG

Journal title

Infectious Disease Reports, 2025-02, Vol.17 (2), p.17

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Background: Immunosuppressed patients still exhibit a high mortality rate due to SARS-CoV-2 infection, up to 21%. Persistent viral load replication and protracted viral symptoms result in a high risk of developing pneumonia, a potential risk of antiviral resistance, and a subsequent delay of onco-hematological treatments. Methods: Hematological pat...

Alternative Titles

Full title

Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8283d0b951404c6ea5a0f214fee70194

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8283d0b951404c6ea5a0f214fee70194

Other Identifiers

ISSN

2036-7449,2036-7430

E-ISSN

2036-7449

DOI

10.3390/idr17020017

How to access this item